RNase-sensitive and RNase-insensitive protective components isolated from Listeria monocytogenes.
Crude ribosomes were isolated from Listeria monocytogenes serotype 4b and separated into two fractions by molecular sieve chromatography. Chemical analysis indicated that fraction I contained cell envelope components while fraction II contained the ribosomes. Both fractions protected mice against Listeria, but only in combination with the adjuvant dimethyldioctadecylammonium bromide (DDA). RNase-treatment, but not proteinase K-treatment destroyed the protective properties of fraction II, and RNA purified from fraction II also induced protection. Protection induced by fraction I was not affected by either RNase- or proteinase K-treatment. Both subcutaneous and intraperitoneal, but not intravenous administration of fraction I, fraction II, or purified RNA induced significant protection against intraperitoneal infection, the intraperitoneal route of administration being the most effective. All preparations induced high levels of protection 3 to 7 days after administration, but protection was already decreased after 14 days. Protection induced with RNA appeared to be biphasic, because it also protected mice 1 day, but not 2 days after administration. Protection induced with both fraction I and RNA was at least in part non-specific, because both preparations also protected mice against L. monocytogenes serotype 3, Streptococcus pneumoniae and Pseudomonas aeruginosa. Results are discussed in relation to previous work with analogous preparations from P. aeruginosa.
A C
AC
Antonissen
P J
PJ
Lemmens
R
R
Gonggrijp
J F
JF
van den Bosch
C P
CP
van Boven
D000818:Animals; D001426:Bacterial Proteins / Q000032:analysis; D002462:Cell Membrane / Q000276:immunology; D019286:Endopeptidase K; D010450:Endopeptidases / Q000494:pharmacology; D007928:Lethal Dose 50; D008089:Listeria monocytogenes / Q000032:analysis / Q000276:immunology* / Q000502:physiology; D008088:Listeriosis / Q000276:immunology*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D010743:Phospholipids / Q000032:analysis; D011550:Pseudomonas aeruginosa / Q000276:immunology; D000644:Quaternary Ammonium Compounds / Q000276:immunology; D012329:RNA, Bacterial / Q000032:analysis / Q000276:immunology*; D012335:RNA, Ribosomal / Q000276:immunology*; D012260:Ribonucleases / Q000494:pharmacology; D012269:Ribosomal Proteins / Q000032:analysis; D013296:Streptococcus pneumoniae / Q000276:immunology
D001426:Bacterial Proteins; D010743:Phospholipids; D000644:Quaternary Ammonium Compounds; D012329:RNA, Bacterial; D012335:RNA, Ribosomal; D012269:Ribosomal Proteins; C015831:dimethyldioctadecylammonium; D012260:Ribonucleases; D010450:Endopeptidases; D019286:Endopeptidase K